Connaught Japanese joint venture
Executive Summary
C-D Vac will be an equal partnership between Connaught and Japanese firm Daiichi Seiyaku. Connaught said the venture will enable it to develop manufacture and market its new vaccine products in the Japanese market. Daiichi is helping Connaught develop a genetically engineered hepatitis B vaccine.